NIAID Partnerships with Product Development Public-Private Partnerships (R01)

Post Date

July 15th 2009

Application Due Date

October 30th 2009

Funding Opportunity Number

RFA-AI-09-034

CFDA Number(s)

93.856

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .

Funding

• Estimated Total Funding:

  $3700000

• Award Range:

  $None - $None

Grant Description

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), seeks research project grant (R01) applications from established, not-for-profit product development Public-Private Partnerships (PD PPPs) in order to accelerate preclinical research and development of promising preventive, therapeutic, or diagnostic tools, or vector management strategies for neglected infectious diseases. PD PPPs should have a track record of development of interventions for neglected infectious diseases of global importance, and highest prevalence in low income countries for which commercial markets provide insufficient incentives for product development. These diseases include malaria, tuberculosis, Neglected Tropical Diseases (see the following link for a list of NTDs: http://www3.niaid.nih.gov/topics/tropicalDiseases/research/examples.htm), and, where relevant, their vectors. Projects must include milestones and timelines to support projects on various aspects of preclinical development and IND enabling studies (e.g. validation of targets for intervention, process development, formulation, toxicology etc.) as well as a product development plan. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. NIAID expects to award $3.7 million in total costs in response to this FOA in FY 2010; the anticipated number of awards is 5-8.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-034.html